BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 29273831)

  • 1. Synergism between apolipoprotein E Ɛ4 allele and paraoxonase (PON1) 55-M allele is associated with risk of systemic lupus erythematosus.
    Tanhapour M; Miri A; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Pourmotabbed T; Shakiba E
    Clin Rheumatol; 2018 Apr; 37(4):971-977. PubMed ID: 29273831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
    Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
    Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase (PON1) 55 polymorphism and association with systemic lupus erythematosus.
    Bahrehmand F; Vaisi-Raygani A; Ahmadi R; Kiani A; Rahimi Z; Tavilani H; Pourmotabbed T
    Iran J Allergy Asthma Immunol; 2013 Jul; 12(3):211-9. PubMed ID: 23893804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
    Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
    Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt.
    Ibrahim AA; El-Lebedy D; Ashmawy I; Hady MA
    Clin Rheumatol; 2017 Jun; 36(6):1305-1310. PubMed ID: 28185016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress.
    Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Ardalan M; Vaisi-Raygani H; Shakiba E; Pourmotabbed T
    Lupus; 2015 May; 24(6):597-605. PubMed ID: 25416694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between activity and genotypes of paraoxonase1 L
    Tanhapour M; Shahmohamadnejad S; Vaisi-Raygani A; Kiani A; Shakiba Y; Rahimi Z; Bahrehmand F; Shakiba E; Vaisi-Raygani AA; Alibakhshi R; Eivazi A; Pourmotabbed T
    Mol Biol Rep; 2019 Feb; 46(1):741-749. PubMed ID: 30506510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus.
    Dasgupta S; Demirci FY; Dressen AS; Kao AH; Rhew EY; Ramsey-Goldman R; Manzi S; Kammerer CM; Kamboh MI
    BMC Med Genet; 2011 Jan; 12():7. PubMed ID: 21223581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin type 1 receptor A1166C polymorphism and systemic lupus erythematosus: correlation with cellular immunity and oxidative stress markers.
    Baniamerian H; Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Pourmotabbed T
    Lupus; 2017 Dec; 26(14):1534-1539. PubMed ID: 28530466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients.
    Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Navabi SJ; Shakiba E; Hassanzadeh N; Pourmotabbed T
    Lupus; 2012 May; 21(6):616-24. PubMed ID: 22323339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of L55M and Q192R polymorphisms of paraoxonase-1 gene with preeclampsia.
    Yaghmaei M; Hashemi M; Azarian A; Moazeni-Roodi A; Mokhtari M; Naghavai A; Salimi S; Mohammadi M; Taheri M; Ghavami S
    Arch Med Res; 2011 May; 42(4):324-8. PubMed ID: 21820612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus.
    Tripi LM; Manzi S; Chen Q; Kenney M; Shaw P; Kao A; Bontempo F; Kammerer C; Kamboh MI
    Arthritis Rheum; 2006 Jun; 54(6):1928-39. PubMed ID: 16729301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
    Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of paraoxonase-1(Q192R and L55M) gene polymorphisms and activity with colorectal cancer and effect of surgical intervention.
    Ahmed NS; Shafik NM; Elraheem OA; Abou-Elnoeman SE
    Asian Pac J Cancer Prev; 2015; 16(2):803-9. PubMed ID: 25684529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polymorphisms in the genes of cytochrome oxidase P450 2D6 (CYP2D6), paraoxonase 1 (PON1) and apolipoprotein E (APOE) as risk factors for Parkinson's disease].
    Durić G; Svetel M; Nikolaevic SI; Dragadević N; Gavrilović J; Kostić VS
    Vojnosanit Pregl; 2007 Jan; 64(1):25-30. PubMed ID: 17304721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the cytotoxic T-lymphocyte antigen-4 mutations and the susceptibility to systemic lupus erythematosus; Contribution markers of inflammation and oxidative stress.
    Tanhapour M; Vaisi-Raygani A; Bahrehmand F; Khazaei M; Kiani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):56-61. PubMed ID: 27894401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.
    Fridman O; Gariglio L; Riviere S; Porcile R; Fuchs A; Potenzoni M
    Arch Cardiol Mex; 2016; 86(4):350-357. PubMed ID: 27640339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus.
    Kiss E; Seres I; Tarr T; Kocsis Z; Szegedi G; Paragh G
    Ann N Y Acad Sci; 2007 Jun; 1108():83-91. PubMed ID: 17893973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of angiotensin-converting enzyme (ACE) I/D variation with biochemical parameters and oxidative stress markers in systemic lupus erythematosus patients in west of Iran.
    Kiani A; Elieh-Ali-Komi D; Bahrehmand F; Mostafaei S; Vaisi-Raygani A; Baniamerian H; Aghaz F; Tanhapour M; Shakiba E; Rahimi Z; Pourmotabbed T
    Mol Biol Rep; 2023 Oct; 50(10):8201-8212. PubMed ID: 37561325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.